Search - tctmd.com

Displaying 121 - 140 of 140

Sort: Relevancy | Date

Presentation TCT 2013

The Common Dilemma of Managing Operator Learning Curve Issues and Evolving Clinical Trial Considerations (eg, Control Populations, Clinical Indications, and Optimal Endpoints)

Presenter: Ted Feldman

October 30, 2013

Presentation TCT 2013

Practical and Meaningful Clinical Trial Pathways for New Mitral Valve Therapies

Presenter: Paul Grayburn

October 30, 2013

Presentation TCT 2013

Clinical Trial Alternatives for New LAA Occlusion Devices: For High-Risk AF Patients Who Are Tolerant to Anticoagulation or Poor Anticoagulation Candidates Due to Bleeding Risks...

Presenter: Brian Whisenant

October 30, 2013

News Conference News TCT 2013

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

October 30, 2013

News Conference News ESC 2013

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

Yael L. Maxwell

September 02, 2013

News Daily News

Cardiac Plug Shows High Success, Low Complication Rate for LAA Closure

L.A. McKeown

May 28, 2013

News Conference News ACC 2013

Will Watchman PREVAIL? Positive Study Pulled from ACC Meeting

Yael L. Maxwell

March 08, 2013

News Daily News

PROTECT AF: Watchman Device Improves Quality of Life in A-fib Patients

Jason Kahn

February 28, 2013

News Daily News

PROTECT AF: El Dispositivo Watchman Mejora la Calidad de Vida de Pacientes con Fibrilación Auricular

Jason Kahn

February 28, 2013

News Daily News

PROTECT AF: Longer Follow-up Provides Clarity on Watchman vs. Warfarin for A-fib

Caitlin E. Cox

January 30, 2013

News Daily News

PROTECT AF: El Seguimiento a Más Largo Plazo Aclara la Situación del Dispositivo Watchman frente a la Warfarina contra la FA

Caitlin E. Cox

January 30, 2013

News Daily News

Snare Device for LAA Closure Safe, Effective in Small A-fib Study

L.A. McKeown

January 16, 2013

Presentation TCT 2012

WaveCrest (Coherex Medical): Device Iteration, Human Outcomes, and Clinical Trial Directions

Presenter: Saibal Kar

October 23, 2012

News Daily News

Novel Device Shows Promise for Safe, Effective LAA Closure

Yael L. Maxwell

October 12, 2012

News Daily News

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

September 27, 2012

News Daily News

Left Atrial Appendage Morphology May Help Predict Stroke Risk in A-fib Patients

July 31, 2012

News Daily News

Watchman Works Just as Well Without Warfarin-Protected Transition

June 01, 2012

News Daily News

Lack of Complete Seal with Watchman Device Common, But No Cause for Alarm

Jason Kahn

March 05, 2012

Presentation ISET 2012

LAA Closure: The Watchman Devices, Lessons Learned from the Clinical Trials

Presenter: Ramon Quesada

January 16, 2012

News Daily News

Ongoing Experience Improves Safety for LAA Closure with Watchman Device

Caitlin E. Cox

January 20, 2011

Advertisement

The Common Dilemma of Managing Operator Learning Curve Issues and Evolving Clinical Trial Considerations (eg, Control Populations, Clinical Indications, and Optimal Endpoints)

Practical and Meaningful Clinical Trial Pathways for New Mitral Valve Therapies

Clinical Trial Alternatives for New LAA Occlusion Devices: For High-Risk AF Patients Who Are Tolerant to Anticoagulation or Poor Anticoagulation Candidates Due to Bleeding Risks...

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

Cardiac Plug Shows High Success, Low Complication Rate for LAA Closure

Will Watchman PREVAIL? Positive Study Pulled from ACC Meeting

PROTECT AF: Watchman Device Improves Quality of Life in A-fib Patients

PROTECT AF: El Dispositivo Watchman Mejora la Calidad de Vida de Pacientes con Fibrilación Auricular

PROTECT AF: Longer Follow-up Provides Clarity on Watchman vs. Warfarin for A-fib

PROTECT AF: El Seguimiento a Más Largo Plazo Aclara la Situación del Dispositivo Watchman frente a la Warfarina contra la FA

Snare Device for LAA Closure Safe, Effective in Small A-fib Study

WaveCrest (Coherex Medical): Device Iteration, Human Outcomes, and Clinical Trial Directions

Novel Device Shows Promise for Safe, Effective LAA Closure

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

Left Atrial Appendage Morphology May Help Predict Stroke Risk in A-fib Patients

Watchman Works Just as Well Without Warfarin-Protected Transition

Lack of Complete Seal with Watchman Device Common, But No Cause for Alarm

LAA Closure: The Watchman Devices, Lessons Learned from the Clinical Trials

Ongoing Experience Improves Safety for LAA Closure with Watchman Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content